Andrea Schietinger, Ph.D.
Molecular programs defining tumor-specific T cell dysfunction and therapeutic reprogrammability
Sloan Kettering Cancer Institute
2 Riverside Circle, Roanoke, VA 24016
This Pioneers in Biomedical Research Seminar is presented by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Group.